MLTX vs REGN: Which Stock is Better?

Side-by-side comparison of Moonlake Immunotherapeutics and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

MLTX

Moonlake Immunotherapeutics

$16.33

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricMLTXREGNWinner
Market Cap$1.16B$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%45.8%REGN

Analyze MLTX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MLTX or REGN a better investment?

Comparing MLTX and REGN: Moonlake Immunotherapeutics has a market cap of $1.16B while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MLTX and REGN?

MLTX (Moonlake Immunotherapeutics) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MLTX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MLTX or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for MLTX.

Which company is more profitable: MLTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to 0.0% for MLTX.

Which is the larger company: MLTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $1.16B for MLTX.

Should I buy MLTX or REGN in 2026?

Both MLTX and REGN have investment merit. MLTX trades at $16.33 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MLTX and REGN stock?

Key differences: Market Cap ($1.16B vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 45.8%).

Popular Stock Comparisons